Market Focus ATT leads in large scale mental health assessment systems using computerized adaptive testing, positioning the company to sell to hospitals, health networks, universities, and corporate wellness programs seeking scalable, evidence based mental health measurements. Approach decision makers in clinical operations, research, and procurement with CAT based assessments and clinically validated tools that can enhance care delivery and outcomes.

Channel Partnerships With a small team, growth via partnerships and channel sales is a strong path. Opportunities exist to partner with larger IT services firms, testing vendors, or education and licensing providers to co sell, integrate, or white label the CAT platform, expanding market reach while leveraging ATT's clinical validation as a differentiator.

EHR Integration Integrating with health IT ecosystems enables embedding adaptive assessments into care workflows. Target EHR vendors, telehealth platforms, and patient portals to streamline data capture, assessment administration, and real time clinician decision support across care settings.

Competitive Edge ATT's claim of clinically validated adaptive mental and behavioral health measures is a compelling differentiator for health systems and payers seeking precise, outcome driven assessments. Use this as a selling point to justify higher value contracts or long term licensing arrangements.

Analytics Value The platform's data and analytics capabilities can support outcomes research, benchmarking, and population health insights, appealing to academic medical centers, research institutions, and government funded programs looking to scale mental health measurement and research.